Back To Top

24.03.2018

CDK4 and CDK6 inhibitors in breast cancer
ESMO Symposium on Signalling Pathways in Cancer 2018 - Educational session
24.03.2018, 13:30 - 15:00, Auditorium
Chair(s):
Presentations: 5
Interaction between CDKs, CDKI and other targets
ESMO Symposium on Signalling Pathways in Cancer 2018 - Educational session
24.03.2018, 09:00 - 10:50, Auditorium
Chair(s):
Presentations: 6
Role of CDK 4-6 inhibitors across solid tumors
ESMO Symposium on Signalling Pathways in Cancer 2018 - Panel Discussion
24.03.2018, 15:20 - 16:05, Auditorium
Chair(s):
Presentations: 1
The disappointing results of initial CDKI and their role in other disease
ESMO Symposium on Signalling Pathways in Cancer 2018 - Educational session
24.03.2018, 11:10 - 12:40, Auditorium
Chair(s):
Presentations: 4

23.03.2018

Keynote lecture
ESMO Symposium on Signalling Pathways in Cancer 2018 - Keynote lecture
23.03.2018, 11:45 - 12:30, Auditorium
Chair(s):
Presentations: 1
Preclinical evidence of efficacy
ESMO Symposium on Signalling Pathways in Cancer 2018 - Educational session
23.03.2018, 16:40 - 18:10, Auditorium
Chair(s):
Presentations: 5
The concept of CDK inhibition according to the targeted CDK subtype
ESMO Symposium on Signalling Pathways in Cancer 2018 - Educational session
23.03.2018, 14:30 - 16:20, Auditorium
Chair(s):
Presentations: 6
The role of CDK along the mitotic process in normal and pathological condition
ESMO Symposium on Signalling Pathways in Cancer 2018 - Educational session
23.03.2018, 13:20 - 14:30, Auditorium
Chair(s):
Presentations: 3
Welcome and introduction
ESMO Symposium on Signalling Pathways in Cancer 2018 - Educational session
23.03.2018, 11:30 - 11:45, Auditorium
Chair(s):
Presentations: 1
Give Feedback

© 2016 CTI MEETING TECHNOLOGY. All rights reserved.